相关实验视频
Updated: Jun 26, 2025

09:03
Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
6.9K
低毒瘤微环境:破坏自然杀手细胞功能
Yongfei Zhang1, Feifei Guo1, Yufeng Wang1
1Cancer Center, the First Hospital of Jilin University, Changchun 130021, China.
概括
瘤微环境中的缺氧会损害自然杀手 (NK) 细胞的功能,限制它们在癌症免疫治疗中的有效性. 向缺氧对于增强NK细胞治疗和改善抗瘤结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 免疫疗法已经在癌症治疗方面取得了进展,但自然杀手 (NK) 细胞的疗效是有限的.
- 瘤微环境 (TME) 通常具有缺氧特征,促进瘤生长和治疗耐药性.
- 缺氧会对NK细胞功能产生负面影响,阻碍其治疗潜力.
研究的目的:
- 为了研究低氧瘤微环境对NK细胞功能的影响.
- 突出了解缺氧对于改善NK细胞基癌症免疫疗法的重要性.
主要方法:
- 这项研究回顾了对NK细胞,缺氧和TME的现有研究.
- 分析重点是缺氧影响NK细胞活动和治疗结果的机制.
主要成果:
- 在TME内的缺氧是有效NK细胞免疫治疗的重要障碍.
- 在低氧条件下NK细胞功能受损有助于治疗限制.
结论:
- 针对TME中缺氧是一种有前途的策略,可以提高NK细胞治疗的疗效.
- 对低氧-NK细胞相互作用的进一步研究对于推进癌症治疗至关重要.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
901
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
901
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518

